Search

Filters
Clear All
  • 22
  • 61
  • 2
  • 701

Phase

  • 1
  • 18
  • 18
  • 54
  • 7
  • 74
  • 5
  • 599
  • 703
  • 309
  • 760
  • 26

Found 786 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

S
Scott Goebel, MD
1 month - 79 years
All genders
Phase 2
Interventional
What is the purpose of this study?Related donor Adenovirus (ADV) specific cytotoxic T cells (CTLs) manufactured with theyi CliniMACS Prodigy Cytokine Capture System will be administered intravenously in inhildren, adolescents and young adults with refractory ADV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) ord organ …
S
Scott Goebel, MD
1 month - 30 years
All genders
Phase 2
Interventional
What is the purpose of this study?CMV cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults (CAYA) with refractory cytomegalovirus (CMV) infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ …
N
Nabil Adra, MD
18 years or above
All genders
Phase 2
Interventional
What is the purpose of this study?This is an open label randomized phase II trial of maintenance oral etoposide vs. observationwith relapsed GCT treated with high-dose chemotherapy (HDCT) and peripheral-blood(PBSCT).THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened …
M
Marissa Just
30 years or below
All genders
Phase 2
Interventional
What is the purpose of this study?This phase II trial studies how well combination chemotherapy works in treating patients withwly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FHWT) that have come back (relapsed). Drugs used in chemotherapy regimens suchH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, …
F
Francesca Duncan
50 years - 80 years
All genders
Interventional
Lung cancer is the leading cause of cancer death in the United States among men and women. Lung cancer screening using low-dose CT scan can identify lung cancer at its’ earliest stage when more curative treatment options are available. However, only 4-6% of people eligible for lung cancer screening get …
 Are you or someone you love receiving treatment for opioid addiction?
R
R Andrew Chambers, MD
18 years - 65 years
All genders
Phase 1
Interventional
Are you interested in being opioid-free? Join our study!Researchers at Indiana University School of Medicine are looking for volunteers to take part in a study to test an investigational drug called Tezampanel for opioid withdrawal. The term “investigational drug” means it is not approved by the Food and Drug Administration …
P
Phuongthao Quan
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in adult subjects diagnosed with generalized epilepsy and experiencing probable or possible PGTCS (with or without other subtypes of generalized …
B
Beatrice Stefanescu
10 hours or below
All genders
Phase 2
Interventional
What is the purpose of this study?Hypoxic-ischemic encephalopathy (HIE) affects approximately 4,000 to 12,000 persons annually in the United States. Mortality from HIE has been reported up to 60%, with at least 25% of survivors left with significant neurocognitive disability. Despite this vital unmet medical need, no pharmacological adjunct or …
T
Tina Zhang
2 years - 18 years
All genders
Interventional
What is this study about?The objective of this study is to assess the pharmacokinetics (PK), efficacy, and safety of risankizumab in pediatric subjects with moderately to severely active CD aged 2 to < 18 years old who have had intolerance or inadequate response to aminosalicylates, oral locally acting corticosteroids, systemic …
R
Raghu Motaganahalli, MD
20 years - 80 years
All genders
Interventional
What is this study about?The PERFORMANCE III study is a prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in subjects at elevated risk for carotid endarterectomy (CEA).Eligible patients greater than or equal to …
41 - 50 of 786